SCHEMBL4873683

SCHEMBL4873683

COc1cccc(C2(CCNS(=O)(=O)NC(=O)O)CCC(NC(c3ccccc3)c3ccccc3)CC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ICMT O60725 6/20 0.39
OPRM1 P35372 2/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
OPRL1 P41146 1/20 0.37
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
MTNR1A P48039 2/20 0.37
MTNR1B P49286 2/20 0.37
MGLL Q99685 1/20 0.36
SOAT1 P35610 2/20 0.36
NPY1R P25929 1/20 0.36
GRIN2B Q13224 2/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
DRD1 P21728 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4873673 1.00 ICMT (0.39) ICMTOPRM1OPRD1OPRK1OPRL1
SCHEMBL4873677 1.00 ICMT (0.39) ICMTOPRM1OPRD1OPRK1OPRL1
SCHEMBL4876769 0.91 ALDH1A1 (0.42) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL4876775 0.91 ALDH1A1 (0.42) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL4876672 0.85 ICMT (0.41) ICMTALDH1A1MEN1KMT2ASOAT1
SCHEMBL4876680 0.85 ICMT (0.41) ICMTALDH1A1MEN1KMT2ASOAT1
SCHEMBL4876664 0.85 ICMT (0.41) ICMTALDH1A1MEN1KMT2ASOAT1
SCHEMBL4881042 0.84 OPRM1 (0.41) ICMTOPRM1OPRD1OPRK1OPRL1
SCHEMBL4871899 0.82 MMP1 (0.41) ICMTOPRM1OPRL1ALDH1A1MEN1
SCHEMBL4871907 0.82 MMP1 (0.41) ICMTOPRM1OPRL1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 ICMT 4335/4885OPRM1 1290/4885OPRD1 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.